Skip to main content

Table 2 Correlation of pathological parameters with HRV in gastric cancer

From: Low heart rate variability relates to the progression of gastric cancer

 

SDNN (ms)

P value

RMSSD (ms)

P value

Histological type

 

0.109

 

0.113

 Differentiated (n = 99)

20.89 ± 17.56

 

24.05 ± 23.09

 

 Undifferentiated (n = 283)

18.35 ± 11.84

 

20.80 ± 15.13

 

T

 

0.000

 

0.000

 T1 (n = 20)

29.96 ± 21.96

 

35.75 ± 26.28

 

 T2 (n = 57)

24.96 ± 16.50

 

27.41 ± 22.07

 

 T3 (n = 280)

17.43 ± 11.86

 

19.79 ± 15.58

 

 T4 (n = 26)

14.51 ± 6.64

 

17.98 ± 10.03

 

LN involvement

 

0.000

 

0.000

 Negative (n = 78)

29.23 ± 19.64

 

31.09 ± 26.23

 

 Positive (n = 305)

16.40 ± 10.01

0.363

19.22 ± 13.58

0.153

  N1 (n = 116)

17.40 ± 10.45

 

21.00 ± 15.67

 

  N2 (n = 165)

15.67 ± 9.82

 

17.85 ± 12.41

 

  N3 (n = 24)

16.52 ± 9.10

 

20.07 ± 9.10

 

Metastasis

 

0.004

 

0.021

 No (n = 348)

19.64 ± 19.94

 

22.30 ± 18.09

 

 Yes (n = 35)

12.70 ± 6.51

 

15.10 ± 8.77

 

TNM stage

 

0.000

 

0.000

 I + II (n = 100)

28.24 ± 18.07

 

30.89 ± 25.35

 

 III + IV (n = 283)

15.75 ± 9.69

 

18.38 ± 13.30

 

Liver metastasis

 

0.085

 

0.100

 No (n = 374)

19.20 ± 13.66

 

21.87 ± 17.68

 

 Yes (n = 9)

11.30 ± 5.67

 

12.12 ± 7.15

 

Peritoneal metastasis

 

0.006

 

0.025

 No (n = 352)

19.58 ± 13.88

 

22.23 ± 18.01

 

 Yes (n = 31)

12.56 ± 6.72

 

14.88 ± 9.02

 
  1. SDNN standard deviation of all normal-to-normal intervals, RMSSD root mean square successive difference, LN lymph node